Addressing the Pervasive Gaps in Modern Lymphoma Care

For many in the clinical community, "unmet need" is more than just a research term—it is a daily reality encountered in every patient room. Matthew J. Matasar, MD, chief of the Division of Blood Disorders at the Rutgers Cancer Institute, offers a candid reflection on the motivations that drive oncologic research and the persistent gaps in care across the spectrum of B-cell, T-cell, and Hodgkin lymphomas.

While the field has seen remarkable progress, the clinical perspective remains focused on the opportunities still at hand: achieving higher cure rates, extending durations of remission, and mitigating both acute and long-term toxicities. Dr Matasar moves past the clinical jargon to address the shared mission of every investigator and practitioner: the refusal to settle for current outcomes when there is still room to "do better" for patients.